These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6120829)

  • 1. Glucocorticoids down-regulate somatostatin receptors on pituitary cells in culture.
    Schonbrunn A
    Endocrinology; 1982 Apr; 110(4):1147-54. PubMed ID: 6120829
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of adrenocorticotropic hormone production by glucocorticoids in mouse pituitary tumor cells.
    Watanabe H; Nicholson WE; Orth DN
    Endocrinology; 1973 Aug; 93(2):411-6. PubMed ID: 4352443
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential regulation of thyrotropin releasing hormone receptors in neoplastic rodent mammotropic, adrenocorticotropic and thyrotropic pituitary cells in culture.
    Peck V; Gershengorn MC
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1144-6. PubMed ID: 6246145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of peptide binding to specific receptors on rat pituitary cells by tumor-promoting phorbol esters: decreased binding of thyrotropin-releasing hormone and somatostatin as well as epidermal growth factor.
    Osborne R; Tashjian AH
    Cancer Res; 1982 Nov; 42(11):4375-81. PubMed ID: 6127158
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucocorticoid receptors in pituitary tumor cells. I. Cytosol receptors.
    Watanabe H; Orth DN; Toft DO
    J Biol Chem; 1973 Nov; 248(22):7625-30. PubMed ID: 4356254
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyrotropin-releasing hormone modulation of uridine uptake in rat pituitary cells. Characterization of the responses.
    Martin TF; Cort AM; Tashjian AH
    J Biol Chem; 1978 Jan; 253(1):99-105. PubMed ID: 201625
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation of somatostatin receptors by thyrotropin-releasing hormone in a clonal pituitary cell strain.
    Schonbrunn A; Tashjian AH
    J Biol Chem; 1980 Jan; 255(1):190-8. PubMed ID: 6243122
    [No Abstract]   [Full Text] [Related]  

  • 8. Establishment in culture of a multihormone-secreting cell strain derived from the MtT/F4 rat pituitary tumor.
    Richardson UI
    J Cell Physiol; 1976 Jul; 88(3):287-96. PubMed ID: 178673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid temperature-dependent transformation of the thyrotropin-releasing hormone-receptor complex in rat pituitary tumor cells.
    Hinkle PM; Kinsella PA
    J Biol Chem; 1982 May; 257(10):5462-70. PubMed ID: 6279601
    [No Abstract]   [Full Text] [Related]  

  • 10. Vasoactive intestinal peptide stimulates hormone release from corticotropic cells in culture.
    Westendorf JM; Phillips MA; Schonbrunn A
    Endocrinology; 1983 Feb; 112(2):550-7. PubMed ID: 6129133
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between receptor binding and biopotency of somatostatin-14 and somatostatin-28 in mouse pituitary tumor cells.
    Srikant CB; Heisler S
    Endocrinology; 1985 Jul; 117(1):271-8. PubMed ID: 2861078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of inositol lipids in hormonal mobilization of cell-associated Ca2+.
    Drummond AH; Knox RJ; Macphee CH
    Biochem Soc Trans; 1985 Feb; 13(1):58-60. PubMed ID: 2987061
    [No Abstract]   [Full Text] [Related]  

  • 13. ACTH response to TRH and somatostatin in Nelson's syndrome.
    Ambrosi B; Bochicchio D; Sartorio A; Rondena M; Riva E
    Horm Metab Res; 1982 Mar; 14(3):164. PubMed ID: 6121749
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the mechanism of action of the inhibitory effect of the somatostatin analog SMS 201-995 on the growth of the prolactin/adrenocorticotropin-secreting pituitary tumor 7315a.
    Lamberts SW; Reubi JC; Uiterlinden P; Zuiderwijk J; van den Werff P; van Hal P
    Endocrinology; 1986 Jun; 118(6):2188-94. PubMed ID: 2870915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prepro-thyrotropin-releasing hormone 178-199 increases sensitivity of AtT-20 cells to dexamethasone.
    Revskoy S; Schwartz J; Redei E
    J Endocrinol; 2001 Dec; 171(3):491-8. PubMed ID: 11739015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cations and colchicine on the release of prolactin and growth hormone by functional pituitary tumor cells in culture.
    Gautvik KM; Tashjian AH
    Endocrinology; 1973 Oct; 93(4):793-9. PubMed ID: 4199493
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlative studies between the presence of thyrotropin-releasing hormone (TRH) receptors and the in vitro stimulation of growth-hormone (GH) secretion in human GH-secreting adenomas.
    Le Dafniet M; Garnier P; Bression D; Brandi AM; Racadot J; Peillon F
    Horm Metab Res; 1985 Sep; 17(9):476-9. PubMed ID: 2864309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin releasing hormone receptors in regulation of prolactin gene expression in GH cells.
    Mu MC; Chakrabarti S; Hanes SD; Biswas DK
    Biochem Biophys Res Commun; 1982 Jun; 106(3):811-7. PubMed ID: 6288036
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthetic thyrotropin releasing factor as a test of pituitary thyrotropin reserve.
    Fleischer N; Lorente M; Kirkland J; Kirkland R; Clayton G; Calderon M
    J Clin Endocrinol Metab; 1972 Apr; 34(4):617-24. PubMed ID: 4335101
    [No Abstract]   [Full Text] [Related]  

  • 20. Somatostatin-14 and somatostatin-28 pretreatment down-regulate somatostatin-14 receptors and have biphasic effects on forskolin-stimulated cyclic adenosine, 3',5'-monophosphate synthesis and adrenocorticotropin secretion in mouse anterior pituitary tumor cells.
    Heisler S; Srikant CB
    Endocrinology; 1985 Jul; 117(1):217-25. PubMed ID: 2861077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.